Skip to main content
British Medical Journal logoLink to British Medical Journal
letter
. 1977 May 28;1(6073):1409. doi: 10.1136/bmj.1.6073.1409-a

Pituitary-dependent Cushing's disease.

S P Deacon
PMCID: PMC1606915  PMID: 193608

Full text

PDF

Page 1409

1409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DOE R. P., VENNES J. A., FLINK E. B. Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing's syndrome. J Clin Endocrinol Metab. 1960 Feb;20:253–265. doi: 10.1210/jcem-20-2-253. [DOI] [PubMed] [Google Scholar]
  2. Krieger D. T., Amorosa L., Linick F. Cyproheptadine-induced remission of Cushing's disease. N Engl J Med. 1975 Oct 30;293(18):893–896. doi: 10.1056/NEJM197510302931802. [DOI] [PubMed] [Google Scholar]
  3. Lamberts S. W., Birkenhäger J. C. Bromocriptine in Nelson's syndrome and Cushing's disease. Lancet. 1976 Oct 9;2(7989):811–811. doi: 10.1016/s0140-6736(76)90656-5. [DOI] [PubMed] [Google Scholar]
  4. Lamberts S. W., Birkenhäger J. C. Effect of bromocriptine in pituitary-dependent Cushing's syndrome. J Endocrinol. 1976 Aug;70(2):315–316. doi: 10.1677/joe.0.0700315. [DOI] [PubMed] [Google Scholar]
  5. SAFFRAN M., SCHALLY A. V., BENFEY B. G. Stimulation of the release of corticotropin from the adenohypophysis by a neurohypophysial factor. Endocrinology. 1955 Oct;57(4):439–444. doi: 10.1210/endo-57-4-439. [DOI] [PubMed] [Google Scholar]
  6. Scapagnini U., Moberg G. P., Van Loon G. R., De Groot J., Ganong W. F. Relation of brain 5-hydroxytryptamine content to the diurnal variation in plasma corticosterone in the rat. Neuroendocrinology. 1971;7(2):90–96. doi: 10.1159/000121956. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES